Literature DB >> 24321043

Tax posttranslational modifications and interaction with calreticulin in MT-2 cells and human peripheral blood mononuclear cells of human T cell lymphotropic virus type-I-associated myelopathy/tropical spastic paraparesis patients.

Fernando Medina1, Sebastian Quintremil, Carolina Alberti, Andres Barriga, Luis Cartier, Javier Puente, Eugenio Ramírez, Arturo Ferreira, Yuetsu Tanaka, Maria Antonieta Valenzuela.   

Abstract

The human retrovirus human T cell lymphotropic virus type-I (HTLV-1) is the etiologic agent of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Axonal degeneration in HAM/TSP patients occurs without neuron infection, with the secreted viral Tax protein proposed to be involved. We previously found that Tax secreted into the culture medium of MT-2 cells (HTLV-1-infected cell line) produced neurite retraction in neuroblastoma cells differentiated to neuronal type. To assess the relevance of Tax posttranslational modifications on this effect, we addressed the question of whether Tax secreted by MT-2 cells and peripheral blood mononuclear cells (PBMCs) of HTLV-1-infected subjects is modified. The interaction of Tax with calreticulin (CRT) that modulates intracellular Tax localization and secretion has been described. We studied Tax localization and modifications in MT-2 cells and its interaction with CRT. Intracellular Tax in MT-2 cells was assessed by flow cytometry, corresponding mainly to a 71-kDa protein followed by western blot. This protein reported as a chimera with gp21 viral protein-confirmed by mass spectrometry-showed no ubiquitination or SUMOylation. The Tax-CRT interaction was determined by confocal microscopy and coimmunoprecipitation. Extracellular Tax from HAM/TSP PBMCs is ubiquitinated according to western blot, and its interaction with CRT was shown by coimmunoprecipitation. A positive correlation between Tax and CRT secretion was observed in HAM/TSP PBMCs and asymptomatic carriers. For both proteins inhibitors and activators of secretion showed secretion through the endoplasmic reticulum-Golgi complex. Tax, present in PBMC culture medium, produced neurite retraction in differentiated neuroblastoma cells. These results suggest that Tax, whether ubiquitinated or not, is active for neurite retraction.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24321043      PMCID: PMC3976577          DOI: 10.1089/AID.2013.0036

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  49 in total

Review 1.  The multifaceted oncoprotein Tax: subcellular localization, posttranslational modifications, and NF-κB activation.

Authors:  Youmna Kfoury; Rihab Nasr; Chloé Journo; Renaud Mahieux; Claudine Pique; Ali Bazarbachi
Journal:  Adv Cancer Res       Date:  2012       Impact factor: 6.242

Review 2.  Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: cellular signaling through NF-kappa B.

Authors:  K T Jeang
Journal:  Cytokine Growth Factor Rev       Date:  2001 Jun-Sep       Impact factor: 7.638

3.  Molecular cloning of cDNA encoding gp68 of adult T-cell leukaemia-associated antigen: evidence for expression of the pX IV region of human T-cell leukaemia virus.

Authors:  K Takeuchi; N Kobayashi; S H Nam; N Yamamoto; M Hatanaka
Journal:  J Gen Virol       Date:  1985-08       Impact factor: 3.891

4.  Exclusive ubiquitination and sumoylation on overlapping lysine residues mediate NF-kappaB activation by the human T-cell leukemia virus tax oncoprotein.

Authors:  Isabelle Lamsoul; Julie Lodewick; Sylvie Lebrun; Robert Brasseur; Arsène Burny; Richard B Gaynor; Françoise Bex
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

Review 5.  Calreticulin: one protein, one gene, many functions.

Authors:  M Michalak; E F Corbett; N Mesaeli; K Nakamura; M Opas
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

6.  Human T-lymphotropic virus, type 1, tax protein triggers microtubule reorientation in the virological synapse.

Authors:  Mohamed Nejmeddine; Amanda L Barnard; Yuetsu Tanaka; Graham P Taylor; Charles R M Bangham
Journal:  J Biol Chem       Date:  2005-06-23       Impact factor: 5.157

7.  Interaction of HTLV-1 Tax protein with calreticulin: implications for Tax nuclear export and secretion.

Authors:  Timothy Alefantis; Katherine E Flaig; Brian Wigdahl; Pooja Jain
Journal:  Biomed Pharmacother       Date:  2007-03-09       Impact factor: 6.529

Review 8.  Human retroviruses after 20 years: a perspective from the past and prospects for their future control.

Authors:  Robert C Gallo
Journal:  Immunol Rev       Date:  2002-07       Impact factor: 12.988

Review 9.  The HTLV-1 Tax interactome.

Authors:  Mathieu Boxus; Jean-Claude Twizere; Sébastien Legros; Jean-François Dewulf; Richard Kettmann; Luc Willems
Journal:  Retrovirology       Date:  2008-08-14       Impact factor: 4.602

10.  High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response.

Authors:  Frederic Toulza; Adrian Heaps; Yuetsu Tanaka; Graham P Taylor; Charles R M Bangham
Journal:  Blood       Date:  2007-12-19       Impact factor: 22.113

View more
  3 in total

1.  Tax and Semaphorin 4D Released from Lymphocytes Infected with Human Lymphotropic Virus Type 1 and Their Effect on Neurite Growth.

Authors:  Sebastián Quintremil; Carolina Alberti; Matías Rivera; Fernando Medina; Javier Puente; Luis Cartier; Eugenio Ramírez; Yuetsu Tanaka; M Antonieta Valenzuela
Journal:  AIDS Res Hum Retroviruses       Date:  2015-09-21       Impact factor: 2.205

Review 2.  Role of HTLV-1 Tax and HBZ in the Pathogenesis of HAM/TSP.

Authors:  Yoshimi Enose-Akahata; Ashley Vellucci; Steven Jacobson
Journal:  Front Microbiol       Date:  2017-12-21       Impact factor: 5.640

Review 3.  Pathogenesis of HTLV-1 infection and progression biomarkers: An overview.

Authors:  Carlos Brites; Maria Fernanda Grassi; Juarez Antônio Simões Quaresma; Ricardo Ishak; Antonio Carlos Rosário Vallinoto
Journal:  Braz J Infect Dis       Date:  2021-07-10       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.